Skip to main content
Caplight Logo









Ceretype Neuromedicine, Inc.

Ceretype Neuromedicine, Inc.

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://ceretype.com/

Last Round

Seed

Jan 4, 2024

Total Funding Raised

$3.67M

Company Overview

Ceretype Neuromedicine, Inc. is a biotechnology company that provides a functional MRI (fMRI) platform to analyze brain circuitry and develop biomarkers for psychiatric and neurological drug development.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical Imaging, Healthcare Analytics, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

functional MRIfMRIneuroimagingprecision psychiatrybiomarker platformCNS drug developmentclinical trial imagingpatient stratificationbrain circuitry mappingdigital biomarkersmedical AIhealthcare analyticsneurotechclinical trial softwareAI in pharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ceretype Neuromedicine, Inc. Comparables

Compare Ceretype Neuromedicine, Inc. with similar companies based on industry and business-model similarity.

Ceretype Neuromedicine, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Karavela
82%
ADM Diagnostics, Inc.
81%
IXICO plc
78%

Ceretype Neuromedicine, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 4, 2024
AcceleratorMar 2, 2023
SeedNov 8, 2021

Key People

Founding team and executive leadership

Emily Stern

CEO, Co-Founder

Founding Team

Ceretype Neuromedicine, Inc. Investors

Notable investors and investment history

Ceretype Neuromedicine, Inc. investors
InvestorRounds
Catalytic Impact FoundationSeed
One Mind AcceleratorSeed, Accelerator
Leafy TunnelSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 72% MoM.

  • Apr 21, 2026

    Monthly visitors increased 174% MoM.

Ceretype Neuromedicine, Inc. Filings

Explore SEC and related filing metadata, where available.

Ceretype Neuromedicine, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ceretype Neuromedicine, Inc.'s valuation, stock price, and market status.

Is Ceretype Neuromedicine, Inc. a public or private company?

Ceretype Neuromedicine, Inc. is a private company.

What is the current stock price of Ceretype Neuromedicine, Inc.?

Ceretype Neuromedicine, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Ceretype Neuromedicine, Inc. worth (valuation)?

Valuation information for Ceretype Neuromedicine, Inc. is not publicly available.

Can I buy Ceretype Neuromedicine, Inc. stock?

Ceretype Neuromedicine, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ceretype Neuromedicine, Inc.'s last funding round?

Ceretype Neuromedicine, Inc.'s most recent funding round was Seed on January 4, 2024.

Who are the main investors in Ceretype Neuromedicine, Inc.?

Key investors in Ceretype Neuromedicine, Inc. include Catalytic Impact Foundation, One Mind Accelerator, Leafy Tunnel.

Will Ceretype Neuromedicine, Inc. IPO soon?

No public IPO plans have been announced for Ceretype Neuromedicine, Inc..

How can I track Ceretype Neuromedicine, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ceretype Neuromedicine, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range4
Year Founded2020
Last FundingJan 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?